DA
Dillon & Associates Portfolio holdings
AUM
$737M
This Quarter Return
+0.89%
1 Year Return
+16.41%
3 Year Return
+121.33%
5 Year Return
+190.29%
10 Year Return
+499.62%
AUM
$220M
AUM Growth
+$220M
(+1.5%)
Cap. Flow
+$2.71M
Cap. Flow
% of AUM
1.23%
Top 10 Holdings %
Top 10 Hldgs %
43.16%
Holding
72
New
2
Increased
21
Reduced
30
Closed
2
Top Buys
| 1 |
Novo Nordisk
NVO
|
$940K |
| 2 |
PayPal
PYPL
|
$730K |
| 3 |
Meta Platforms (Facebook)
META
|
$605K |
| 4 |
Abbott
ABT
|
$566K |
| 5 |
Paycom
PAYC
|
$234K |
Top Sells
| 1 |
Fortive
FTV
|
$648K |
| 2 |
LLTC
Linear Technology Corp
LLTC
|
$315K |
| 3 |
Gilead Sciences
GILD
|
$217K |
| 4 |
Chipotle Mexican Grill
CMG
|
$98K |
| 5 |
Novartis
NVS
|
$90.7K |
Sector Composition
| 1 | Healthcare | 23.48% |
| 2 | Technology | 18.99% |
| 3 | Consumer Staples | 14.95% |
| 4 | Industrials | 9.98% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Exxon Mobil
XOM
$487B
| $545K | 0.25% |
6,050
-31
| -0.5% | -$2.79K |
|
52
Core Laboratories
CLB
$540M
| $522K | 0.24% |
4,350
| – | – |
|
53
Biogen
BIIB
$19.4B
| $506K | 0.23% |
1,780
+40
| +2% | +$11.4K |
|
54
Microsoft
MSFT
$3.77T
| $487K | 0.22% |
7,861
| – | – |
|
|
55
Paycom
PAYC
$12.8B
| $444K | 0.2% |
9,860
+5,205
| +112% | +$234K |
|
|
ESRX
56
DELISTED
Express Scripts Holding Company
ESRX
| $440K | 0.2% |
6,380
+710
| +13% | +$49K |
|
57
Cisco
CSCO
$274B
| $435K | 0.2% |
14,500
-199
| -1% | -$5.97K |
|
58
Genuine Parts
GPC
$19.4B
| $408K | 0.19% |
4,255
-25
| -0.6% | -$2.4K |
|
59
Comerica
CMA
$9.07B
| $351K | 0.16% |
5,157
| – | – |
|
60
Kraft Heinz
KHC
$33.1B
| $307K | 0.14% |
3,525
| – | – |
|
61
IBM
IBM
$227B
| $266K | 0.12% |
1,600
| – | – |
|
62
Target
TGT
$43.6B
| $265K | 0.12% |
3,675
| – | – |
|
63
Eaton
ETN
$136B
| $258K | 0.12% |
3,856
-500
| -11% | -$33.5K |
|
64
AT&T
T
$209B
| $247K | 0.11% |
5,739
| – | – |
|
65
Verizon
VZ
$186B
| $234K | 0.11% |
4,414
+95
| +2% | +$5.04K |
|
66
Bristol-Myers Squibb
BMY
$96B
| $229K | 0.1% |
+3,950
| New | +$229K |
|
67
Emerson Electric
EMR
$74.3B
| $227K | 0.1% |
4,057
| – | – |
|
68
Altria Group
MO
$113B
| $225K | 0.1% |
3,307
| – | – |
|
|
VSM
69
DELISTED
Versum Materials, Inc.
VSM
| $200K | 0.09% |
+7,150
| New | +$200K |
|
|
GCVRZ
70
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $4K | ﹤0.01% |
10,660
| – | – |
|
|
71
Fortive
FTV
$16.2B
| – | – |
-12,701
| Closed | -$648K |
|
|
72
Gilead Sciences
GILD
$140B
| – | – |
-2,750
| Closed | -$217K |
|